| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |